Novavax to Present at the Stifel 2017 Healthcare Conference
08 Novembro 2017 - 7:05PM
YASTEST
GAITHERSBURG, Md., Nov. 08, 2017
(GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced
the Company will present at the Stifel 2017 Healthcare
Conference.
Presentation details are as
follows:
Date: Wednesday, November 15, 2017
Time: 1:15 p.m. - 1:55 p.m. ET
Location: Garrison, 5th Floor, Lotte
New York Palace Hotel, New York City
Live webcast: www.novavax.com, "Investors"/"Events"
A replay of the presentation will
also be accessible under the "Investors/Events" section of the
Novavax website at novavax.com.
About
Novavax
Novavax, Inc. (Nasdaq:NVAX) is a
clinical-stage biotechnology company committed to delivering novel
products to prevent a broad range of infectious diseases. Our
recombinant nanoparticles and Matrix-M(TM) adjuvant technology are
the foundation for groundbreaking innovation that improves global
health through safe and effective vaccines. Additional information
about Novavax is available on the Company's website,
novavax.com.
Contact:
Investor Relations
Novavax, Inc.
Andrea N. Flynn, Ph.D.
Director, Investor & Media Relations
ir@novavax.com
240-268-2000
Westwicke Partners
John Woolford
john.woolford@westwicke.com
443-213-0506
Media
Russo Partners, LLC
David Schull
Maggie Beller
david.schull@russopartnersllc.com
maggie.beller@russopartnersllc.com
212-845-4271
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Novavax, Inc. via Globenewswire
Novavax (NASDAQ:NVAX)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Novavax (NASDAQ:NVAX)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024